Literature DB >> 25451713

Heterozygous deletion of CHL1 gene: detailed array-CGH and clinical characterization of a new case and review of the literature.

Elisa Tassano, Roberta Biancheri, Laura Denegri, Simona Porta, Francesca Novara, Orsetta Zuffardi, Giorgio Gimelli, Cristina Cuoco.   

Abstract

CHL1 gene maps at 3p26.3 and encodes a cell adhesion molecule of the immunoglobulin superfamily highly expressed in the brain. CHL1 regulates neuronal migration and neurite overgrowth in the developing brain, while in mature neurons it accumulates in the axonal membrane and regulates synapse function via the clathrin-dependent pathways. To our knowledge, to date only three familial cases presenting heterozygous deletion of chromosome 3 at band p26.3, including only the CHL1 gene, have been reported. All the patients presented cognitive impairment characterized by learning and language difficulties. Here, we describe a six-year-old boy in which array-CGH analysis disclosed a terminal 3p26.3 deletion. The deletion was transmitted from his normal mother and included only the CHL1 gene. Our patient presented microcephaly, short stature, mild mental retardation, learning and language delay, and strabismus. In our study we compare the phenotypic and molecular cytogenetic features of CHL1 gene deletion cases. Verbal function developmental delay seems to be a common key finding. The concomitance of the genetic and phenotypic alterations could be a good evidence of a new emerging syndrome associated with the deletion of CHL1 gene alone, although the identification of new cases is required. 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25451713     DOI: 10.1016/j.ejmg.2014.09.007

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  9 in total

1.  Constitutional 3p26.3 terminal microdeletion in an adolescent with neuroblastoma.

Authors:  Annalisa Pezzolo; Angela Rita Sementa; Margherita Lerone; Martina Morini; Marzia Ognibene; Raffaella Defferrari; Katia Mazzocco; Massimo Conte; Anna Rita Gigliotti; Alberto Garaventa; Vito Pistoia; Luigi Varesio
Journal:  Cancer Biol Ther       Date:  2017-04-12       Impact factor: 4.742

2.  Partial Trisomy 13q/Monosomy 3p Resulting from a Paternal Reciprocal 3p;13q Translocation in a Boy with Facial Dysmorphism and Hypertrophic Cardiomyopathy.

Authors:  Monica Martin-de Saro; Zyndia Compean; Karina Aguilar; Luz María González-Huerta; Lautaro Plaza-Benhumea; Olga Messina-Baas; Sergio Alberto Cuevas-Covarrubiass
Journal:  Mol Syndromol       Date:  2021-07-20

3.  De novo microduplication of CHL1 in a patient with non-syndromic developmental phenotypes.

Authors:  Orazio Palumbo; Rita Fischetto; Pietro Palumbo; Francesco Nicastro; Francesco Papadia; Leopoldo Zelante; Massimo Carella
Journal:  Mol Cytogenet       Date:  2015-08-16       Impact factor: 2.009

4.  Novel microduplication of CHL1 gene in a patient with autism spectrum disorder: a case report and a brief literature review.

Authors:  Chunyang Li; Chunxue Liu; Bingrui Zhou; Chunchun Hu; Xiu Xu
Journal:  Mol Cytogenet       Date:  2016-06-27       Impact factor: 2.009

5.  CHL1 Is Expressed and Functions as a Malignancy Promoter in Glioma Cells.

Authors:  Zhai Yang; Qing Xie; Cheng-Liang Hu; Qiong Jiang; Hui-Fan Shen; Melitta Schachner; Wei-Jiang Zhao
Journal:  Front Mol Neurosci       Date:  2017-10-17       Impact factor: 5.639

6.  CNTN6 mutations are risk factors for abnormal auditory sensory perception in autism spectrum disorders.

Authors:  O Mercati; G Huguet; A Danckaert; G André-Leroux; A Maruani; M Bellinzoni; T Rolland; L Gouder; A Mathieu; J Buratti; F Amsellem; M Benabou; J Van-Gils; A Beggiato; M Konyukh; J-P Bourgeois; M J Gazzellone; R K C Yuen; S Walker; M Delépine; A Boland; B Régnault; M Francois; T Van Den Abbeele; A L Mosca-Boidron; L Faivre; Y Shimoda; K Watanabe; D Bonneau; M Rastam; M Leboyer; S W Scherer; C Gillberg; R Delorme; I Cloëz-Tayarani; T Bourgeron
Journal:  Mol Psychiatry       Date:  2016-05-10       Impact factor: 15.992

7.  Chromosome 3p Inverted Duplication with Terminal Deletion: Second Postnatal Case Report with Additional Clinical Features.

Authors:  Jacquelyn D Riley; Catherine M Stefaniuk; Francine Erenberg; Angelika L Erwin; Lauren Palange; Caroline Astbury
Journal:  Case Rep Genet       Date:  2019-07-25

8.  CHL1 gene acts as a tumor suppressor in human neuroblastoma.

Authors:  Marzia Ognibene; Gabriella Pagnan; Danilo Marimpietri; Davide Cangelosi; Michele Cilli; Maria Chiara Benedetti; Renata Boldrini; Alberto Garaventa; Francesco Frassoni; Alessandra Eva; Luigi Varesio; Vito Pistoia; Annalisa Pezzolo
Journal:  Oncotarget       Date:  2018-05-25

Review 9.  CHL1 deletion is associated with cognitive and language disabilities - Case report and review of literature.

Authors:  Melissa Tsuboyama; Mohammed Anwar Iqbal
Journal:  Mol Genet Genomic Med       Date:  2021-05-31       Impact factor: 2.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.